DelveInsight Business Research LLP

Albany, NY -- (SBWire) -- 04/19/2019 --House Dust Mite Allergy - Epidemiology and Market Forecast-2027


Approximately 1% to 2% that is 65 to 130 million persons of the world's population is affected with House Dust Mite Allergy.

1. In developed countries, the rate of House Dust Mite Allergy allergic sensitization is much higher.
2. More than 50% of Europeans will suffer from allergic rhinitis in the coming 10 years.
3. Among patients from 15 developed countries in the European Community Respiratory, the mean prevalence of sensitization to House Dust Mite Allergy was 21.7%.

DelveInsight launched a new report on House Dust Mite Allergy - Market Insights, Epidemiology and Market Forecast-2028

Key benefits

1. House Dust Mite Allergy market report covers a descriptive overview and comprehensive insight of the House Dust Mite Allergy epidemiology and House Dust Mite Allergy market in the 7 MM (United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)
2. House Dust Mite Allergy market report provides insights on the current and emerging therapies.
3. House Dust Mite Allergy market report provides a global historical and forecasted market covering drug outreach in 7 MM.
4. House Dust Mite Allergy market report provides an edge that will help in developing business strategies, by understanding trends shaping and driving the House Dust Mite Allergy market.

Request for sample pages

"Immunotherapies like SLIT are expected to drive the market during the forecast period"

House Dust Mite Allergy therapeutic market is majorly dominated by Antihistamines (fexofenadine, loratadine); Nasal corticosteroids (beclometasone), Leukotriene receptor antagonists (montelukast, zafirlukast), Cromolyn sodium and Decongestants (oxymetazoline, phenylephrine, naphazoline). However, many people do not get complete relief from these medicines. Therefore, they are required to take immunotherapy (Allergy-shots). Based on the route of administration, two types of allergy shots are available. These are Subcutaneous Immunotherapy (SCIT) and Sublingual (under-the-tongue) immunotherapy (SLIT). These shots are effective in treating reactions to many allergens including trees, grass, weeds, mold, house dust, dander, and insect stings.

House Dust Mite Allergy market size is believed to experience a positive growth during the forecast period due to the increasing prevalence, rise in the incidence of allergic disorders and expected launch of novel therapies.

House Dust Mite Allergy competitive landscape is set to change due to the advent of targeted immunotherapies like SCIT and SLIT. The launch of upcoming therapies, such as SLIT tablets of HDM allergen extracts (Stallergenes Greer), ToleroMune (Circassia Limited), SUBLIVAC FIX Mite mixture (HAL Allergy Group), MM09 (Inmunotek) along with few other compelling options in the clinical trials, would lead to an increase in the House Dust Mite Allergy market size in the upcoming years.

Companies
1. Stallergenes Greer
2. ALK-Abello
3. ASIT Biotech
4. HAL Allergy Group
5. Circassia Limited
6. Allergopharma
and many others.
Drugs that are involved are
1. ToleroMune
2. SUBLIVAC FIX Mite mixture
3. MM09
And many others
Table of contents

1. Report Introduction
2. House Dust Mite Allergy Market Overview at a Glance
3. House Dust Mite Allergy Disease Background and Overview
4. House Dust Mite Allergy Epidemiology and Patient Population
5. House Dust Mite Allergy : Country- Wise Epidemiology
5.1. United States
5.2.5. Spain
5.2.6. United Kingdom
5.2.7. Japan
6. House Dust Mite Allergy Treatments & Medical Practices
7. House Dust Mite Allergy Marketed Products
7.1. Oralair: Stallergenes-Greer
7.2. Odactra: Merck
8. Emerging Therapies
8.1. Key Cross Competition
8.2. SLIT tablets of HDM allergen extracts: Stallergenes Greer
8.3. SUBLIVAC FIX Mite Mixture: HAL Allergy Group
9. House Dust Mite Allergy : Market Size
10. House Dust Mite Allergy 7MM Country-Wise Market Analysis
10.1. United States Market Size
10.2. Germany Market Size
10.3. France Market Size
10.4. United Kingdom Market Size
10.5. Spain Market Size
10.6. Italy Market Size
10.7. Japan Market Size
11. Market Drivers
12. Market Barriers
13. Report Methodology
13.1. Sources Used
14. DelveInsight Capabilities
15. Disclaimer
16. About DelveInsight